Endo Health's Aveed testosterone injection approved by FDA Endo's operating company Endo Pharmaceuticals received FDA approval of Aveed, testosterone undecanoate, injection for the treatment of adult men with a deficiency or absence of the male hormone testosterone. Aveed is a new prescription medicine indicated to produce serum testosterone levels in the normal range by administration of a single 3-mL intramuscular injection. It is expected to be available in early March.
News For ENDP From The Last 14 Days
Check below for free stories on ENDP the last two weeks.